To The Editors: Eikenella corrodens is a small, nonmotile Gram-negative rod and is a member of the ordinary flora of the oral mucosa. Eikenella species can cause a wide variety of head and neck infections, such as sinusitis, preseptal cellulitis and orbital cellulitis in immunocompromised patients as well as in hosts with normal immunity.1,2 In the literature, there are few cases of orbital cellulitis caused by E. corrodens. We herein report 2 cases of orbital cellulitis due to Eikenella spp. as the complication of untreated sinusitis in previously healthy girls. The first case, a previously healthy 15-year-old girl, was admitted to the pediatric emergency department (PED) complaining of new-onset left eyelid swelling, painful eye movements and chemosis. On physical examination, her eye movements were limited and painful. Significant chemosis and ectropion were observed. Laboratory results were notable for leukocytosis (16000 cells/mm3) and increased C-reactive protein (CRP) (176 mg/L) levels. Orbital computed tomography (CT) revealed orbital cellulitis and subperiosteal abscess as a complication of sinusitis in the left orbit (Fig. 1). The treatment was administered as intravenous (IV) cefotaxime (300 mg/kg/day), vancomycin (60 mg/kg/day) and metronidazole (30 mg/kg/day). Orbital decompression and subperiosteal abscess drainage were performed. Abscess culture grew E. corrodens that was susceptible to penicillin (MIC:0.023), cefuroxime (MIC:1.00) and cefotaxime (MIC:0.064). Vancomycin and metronidazole were discontinued on day 3. After 14 days of IV cefotaxime treatment, she was discharged with oral cefuroxime, and the total treatment period was completed in 21 days.FIGURE 1.: The arrow marks show abcess and the stars show sinusitis in both pictures. A: The orbital CT reveal orbital cellulitis of the left eye and ethmoid sinusitis. B: Orbital CT represents the subperiosteal abscess in the medial extraconal area of the left orbita.The second case, a previously healthy 9-year-old girl, presented to the PED with a 4-day history of painful eye movements. On physical examination, eye movements were painful, and there was proptosis in her left eye. In the laboratory, acute phase reactants were normal (CRP:26 mg/L, procalcitonin:<0.06 µg/L) without leukocytosis (WBC:11500 cells/mm3). Orbital CT showed diffuse sinusitis and subperiosteal abscess in the left orbital medial extraconal region (Fig. 1). Treatment was arranged as IV cefotaxime, vancomycin and metronidazole. Orbital decompression and subperiosteal abscess drainage were performed. E. corrodens grew in abscess culture, which was susceptible to ampicillin (MIC:0,064), cefotaxime (MIC:0,16), clindamycin (MIC:0,75) and meropenem (MIC:0,16). Her treatment was continued with IV ampicillin-sulbactam (300 mg/kg/day) for 10 days. She was discharged with amoxicillin/clavulanic acid, and the total treatment was completed in 21 days. Acute sinusitis is a common condition that can cause severe complications due to expanding to the surrounding structures, including the eye and the brain.3 Orbital cellulitis is a rare but important complication of acute sinusitis, as it may result in vision loss.4 Although Streptococcus and Staphylococcus spp. are the most common, other less frequent oral flora members, including anaerobes and facultative anaerobic agents such as E. corrodens, may also cause the same clinical presentations. In routine culture, E. corrodens was challenging to detect due to growth in 72 hours in an atmosphere of 5%–15% CO2, 35–37 °C and 100% humidity.5E. corrodens is usually susceptible to penicillin, second- and third-generation cephalosporins, and carbapenem but is resistant to clindamycin, macrolide, metronidazole and aminoglycoside.2 Antibiotic susceptibility tests are important in terms of guiding for appropriate treatment. In summary, we present 2 previously healthy children who developed orbital cellulitis due to Eikenella corrodens. Early diagnosis, appropriate surgical drainage, and targeted medical treatment due to antibiotic susceptibility will improve the outcomes.